MEETING MULTIDISCIPLINARE CASI CLINICI IN ONCOLOGIA 2026

1. 1.Yelena Y Janjigian 1, Eric Van Cutsem 2, Kei Muro 3, Zev Wainberg 4, Salah-Eddin Al-Batran 5, Woo Jin Hyung 6, Daniela Molena 7, Michelle Marcovitz 8, Dario Ruscica 9, Scott H Robbins 10, Alejandra Negro 10, Josep Tabernero 11. MATTERHORN: phase III study of durvalumab plus FLOT chemotherapy in resectable gastric/gastroesophageal junction cancer. Future Oncol 2022 Jun;18(20):2465-2473. doi: 10.2217/fon-2022-0093. Epub 2022 May 10.. 2022
   Articolo scientificoFuture Oncol 2022 Jun;18(20):2465-2473. doi: 10.2217/fon-2022-0093. Epub 2022 May 10.Leggi il PDF gratuito
2. 2.Michele Reni 1, Marina Macchini 2, Giulia Orsi 2, Letizia Procaccio 3, Giuseppe Malleo 4, Catia Carconi 5, Ilario Giovanni Rapposelli 6, Katia Bencardino 7, Mario Scartozzi 8, Gianpaolo Balzano 9, Domenico Tamburrino 10, Barbara Merelli 11, Elisa Sperti 12, Giulio Belfiori 9, Nicole Liscia 2, Silvia Bozzarelli 13, Mariacristina Di Marco 14, Emiliano Tamburini 15, Michele Milella 16, Sara Lonardi 3, Giorgio Ercolani 17, Michele Mazzola 18, Diego Palumbo 19, Valter Torri 20, Massimo Falconi 10. Preoperative mFOLFIRINOX versus PAXG for stage I-III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trial. Lancet 2026 Dec 20;406(10522):2945-2956. doi: 10.1016/S0140-6736(25)01685-X. Epub 2025 Nov 20.. 2026
   Articolo scientificoLancet 2026 Dec 20;406(10522):2945-2956. doi: 10.1016/S0140-6736(25)01685-X. Epub 2025 Nov 20.Leggi il paperCerca versione gratuita
3. 3.Do-Youn Oh 1, Aiwu Ruth He 2, Shukui Qin 3, Li-Tzong Chen 4 5 6, Takuji Okusaka 7, Arndt Vogel 8, Jin Won Kim 9, Thatthan Suksombooncharoen 10, Myung Ah Lee 11, Masayuki Kitano 12, Howard Burris 13, Mohamed Bouattour 14, Suebpong Tanasanvimon 15, Mairéad G McNamara 16, Renata Zaucha 17, Antonio Avallone 18, Benjamin Tan 19, Juan Cundom 20, Choong-Kun Lee 21, Hidenori Takahashi 22, Masafumi Ikeda 23, Jen-Shi Chen 24, Julie Wang 25, Mallory Makowsky 25, Nana Rokutanda 25, Philip He 25, John F Kurland 25, Gordon Cohen 25, Juan W Valle 16. Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract Cancer. NEJM Evid. 2022 Aug;1(8):EVIDoa2200015. doi: 10.1056/EVIDoa2200015. Epub 2022 Jun 1.. 2022
   Articolo scientificoNEJM Evid. 2022 Aug;1(8):EVIDoa2200015. doi: 10.1056/EVIDoa2200015. Epub 2022 Jun 1.Leggi il paperCerca versione gratuita
4. 4.Gerald W Prager 1, Julien Taieb 1, Marwan Fakih 1, Fortunato Ciardiello 1, Eric Van Cutsem 1, Elena Elez 1, Felipe M Cruz 1, Lucjan Wyrwicz 1, Daniil Stroyakovskiy 1, Zsuzsanna Pápai 1, Pierre-Guillaume Poureau 1, Gabor Liposits 1, Chiara Cremolini 1, Igor Bondarenko 1, Dominik P Modest 1, Karim A Benhadji 1, Nadia Amellal 1, Catherine Leger 1, Loïck Vidot 1, Josep Tabernero 1;. Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer. SUNLIGHT Investigators NEJM 2023 May 4;388(18):1657-1667. doi: 10.1056/NEJMoa2214963.. 2023
   Articolo scientificoSUNLIGHT Investigators NEJM 2023 May 4;388(18):1657-1667. doi: 10.1056/NEJMoa2214963.Leggi il PDF gratuito
5. 5.Andrea Cercek 1, Melissa Lumish 1, Jenna Sinopoli 1, Jill Weiss 1, Jinru Shia 1, Michelle Lamendola-Essel 1, Imane H El Dika 1, Neil Segal 1, Marina Shcherba 1, Ryan Sugarman 1, Zsofia Stadler 1, Rona Yaeger 1, J Joshua Smith 1, Benoit Rousseau 1, Guillem Argiles 1, Miteshkumar Patel 1, Avni Desai 1, Leonard B Saltz 1, Maria Widmar 1, Krishna Iyer 1, Janie Zhang 1, Nicole Gianino 1, Christopher Crane 1, Paul B Romesser 1, Emmanouil P Pappou 1, Philip Paty 1, Julio Garcia-Aguilar 1, Mithat Gonen 1, Marc Gollub 1, Martin R Weiser 1, Kurt A Schalper 1, Luis A Diaz Jr 1. PD-1 Blockade in Mismatch Repair-Deficient, Locally Advanced Rectal Cancer. NEJM 2022 Jun 23;386(25):2363-2376. doi: 10.1056/NEJMoa2201445. Epub 2022 Jun 5.. 2022
   Articolo scientificoNEJM 2022 Jun 23;386(25):2363-2376. doi: 10.1056/NEJMoa2201445. Epub 2022 Jun 5.Leggi il PDF gratuito
6. 6.Julien Taieb 1, Mehdi Karoui 2. FOxTROT: Are We Ready to Dance?. J Clinical Oncol 2023 Mar 10;41(8):1514-1517. doi: 10.1200/JCO.22.02108.. 2023
   Articolo scientificoJ Clinical Oncol 2023 Mar 10;41(8):1514-1517. doi: 10.1200/JCO.22.02108.Leggi il paperCerca versione gratuita
7. 7.Clara Montagut 1, Joana Vidal 1. Liquid Biopsy for Precision Adjuvant Chemotherapy in Colon Cancer. NEJM 2022 Jun 16;386(24):2330-2331. doi: 10.1056/NEJMe2204625. Epub 2022 Jun 4.. 2022
   Articolo scientificoNEJM 2022 Jun 16;386(24):2330-2331. doi: 10.1056/NEJMe2204625. Epub 2022 Jun 4.Leggi il paperCerca versione gratuita
8. 8.Floris S Verheij 1, Dana M Omer 1, Hannah Williams 1, Sabrina T Lin 2, Li-Xuan Qin 2, James T Buckley 1, Hannah M Thompson 1, Jonathan B Yuval 1, Jin K Kim 1, Richard F Dunne 3, Jorge Marcet 4, Peter Cataldo 5, Blase Polite 6, Daniel O Herzig 7, David Liska 8, Samuel Oommen 9, Charles M Friel 10, Charles Ternent 11, Andrew L Coveler 12, Steven Hunt 13, Anita Gregory 14, Madhulika G Varma 15, Brian L Bello 16, Joseph C Carmichael 17, John Krauss 18, Ana Gleisner 19, José G Guillem 20, Larissa Temple 21, Karyn A Goodman 22, Neil H Segal 23, Andrea Cercek 23, Rona Yaeger 23, Garrett M Nash 1, Maria Widmar 1, Iris H Wei 1, Emmanouil P Pappou 1, Martin R Weiser 1, Philip B Paty 1, J Joshua Smith 1, Abraham J Wu 24, Marc J Gollub 25, Leonard B Saltz 23, Julio Garcia-Aguilar. Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA Trial. J Clin Oncol 2024 Feb 10;42(5):500-506. doi: 10.1200/JCO.23.01208. Epub 2023 Oct 26.. 2024
   Articolo scientificoJ Clin Oncol 2024 Feb 10;42(5):500-506. doi: 10.1200/JCO.23.01208. Epub 2023 Oct 26.Leggi il PDF gratuito
9. 9.Thierry Conroy 1, Jean-François Bosset 2, Pierre-Luc Etienne 3, Emmanuel Rio 4, Éric François 5, Nathalie Mesgouez-Nebout 6, Véronique Vendrely 7, Xavier Artignan 8, Olivier Bouché 9, Dany Gargot 10, Valérie Boige 11, Nathalie Bonichon-Lamichhane 12, Christophe Louvet 13, Clotilde Morand 14, Christelle de la Fouchardière 15, Najib Lamfichekh 16, Béata Juzyna 17, Claire Jouffroy-Zeller 17, Eric Rullier 7, Frédéric Marchal 18, Sophie Gourgou 19, Florence Castan 19, Christophe Borg 2;. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Unicancer Gastrointestinal Group and Partenariat de Recherche en Oncologie Digestive (PRODIGE) Group Lancet Oncol 2021 May;22(5):702-715. doi: 10.1016/S1470-2045(21)00079-6. Epub 2021 Apr 13.. 2021
   Articolo scientificoUnicancer Gastrointestinal Group and Partenariat de Recherche en Oncologie Digestive (PRODIGE) Group Lancet Oncol 2021 May;22(5):702-715. doi: 10.1016/S1470-2045(21)00079-6. Epub 2021 Apr 13.Leggi il paperCerca versione gratuita
10. 10.Renu R Bahadoer 1, Esmée A Dijkstra 2, Boudewijn van Etten 3, Corrie A M Marijnen 4, Hein Putter 5, Elma Meershoek-Klein Kranenbarg 1, Annet G H Roodvoets 1, Iris D Nagtegaal 6, Regina G H Beets-Tan 7, Lennart K Blomqvist 8, Tone Fokstuen 9, Albert J Ten Tije 10, Jaume Capdevila 11, Mathijs P Hendriks 12, Ibrahim Edhemovic 13, Andrés Cervantes 14, Per J Nilsson 15, Bengt Glimelius 16, Cornelis J H van de Velde 1, Geke A P Hospers 17;. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. RAPIDO collaborative investigators Lancet Oncol 2021 Jan;22(1):29-42. doi: 10.1016/S1470-2045(20)30555-6. Epub 2020 Dec 7.. 2021
    Articolo scientificoRAPIDO collaborative investigators Lancet Oncol 2021 Jan;22(1):29-42. doi: 10.1016/S1470-2045(20)30555-6. Epub 2020 Dec 7.Cerca su Google Scholar
11. 11.Talha Ashraf Gondal 1, Noman Chaudhary 2, Husnaat Bajwa 1, Aribah Rauf 3, Duc Le 1 4, Shahid Ahmed. Anal Cancer: The Past, Present and Future. Curr Oncol 2023 Mar 11;30(3):3232-3250. doi: 10.3390/curroncol30030246.. 2023
    Articolo scientificoCurr Oncol 2023 Mar 11;30(3):3232-3250. doi: 10.3390/curroncol30030246.Leggi il PDF gratuito

I link ai libri possono contenere un codice affiliato Amazon: in qualità di affiliato, ECM Finder potrebbe ricevere una commissione sugli acquisti idonei, senza alcun costo aggiuntivo per te. I link ai paper rimandano alla fonte scientifica (DOI, versione open-access o ricerca accademica).